• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙酮尿症的耗时性:一项横断面研究,调查荷兰苯丙酮尿症的时间负担和成本。

The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.

机构信息

MAPI Consultancy, Houten, The Netherlands.

出版信息

Mol Genet Metab. 2013 Jul;109(3):237-42. doi: 10.1016/j.ymgme.2013.05.003. Epub 2013 May 10.

DOI:10.1016/j.ymgme.2013.05.003
PMID:23731533
Abstract

BACKGROUND

Phenylketonuria (PKU) is a rare inborn error of metabolism that affects the ability of patients to metabolise phenylalanine (Phe). Lifelong management of blood Phe levels is required in order to avoid the complications associated with PKU. This constitutes a severely protein restricted diet, and regular monitoring of Phe levels. Management of PKU may be costly and time-consuming for adult patients or caregivers of PKU-affected children. A cross-sectional study was performed with patients or their caregivers in the Netherlands to gain insight into the personal time burden and cost of living with PKU.

METHODS

A systematic literature review was performed to identify all aspects of PKU management that may pose a financial or time burden on patients or caregivers. Findings were confirmed through interviews with PKU experts and feedback from patients and caregivers, and consolidated into a questionnaire that aimed to evaluate the impact of each of these factors. Early and continuously treated adult patients and caregivers from seven metabolic centres were recruited to complete the questionnaire online.

RESULTS

22 adult patients and 24 caregivers participated in the study. Managing a Phe-restricted diet represented an extra time burden of 1 h and 24 min for caregivers and 30 min for adult patients per day. Caregivers reported a significantly higher time burden than adult patients. The median total out-of-pocket cost (OOPC) for patients was €604 annually, with 99% of expenditure on low-protein food products. Greater disease severity was significantly associated with increased OOPC and time burden for both adult patients and caregivers.

CONCLUSIONS

Management of PKU is associated with a considerable time burden for both caregivers of children with PKU and adult patients. Caregivers of PKU-affected children reported a significantly higher time burden than adult patients. The OOPC of caregivers and patients was mainly driven by the expenditure on low protein food.

摘要

背景

苯丙酮尿症(PKU)是一种罕见的代谢性遗传疾病,会影响患者代谢苯丙氨酸(Phe)的能力。为了避免与 PKU 相关的并发症,患者需要终身控制血液 Phe 水平。这就需要他们遵循严格限制蛋白质的饮食,并定期监测 Phe 水平。成年患者或 PKU 患儿的照顾者在管理 PKU 方面可能需要付出高昂的时间和经济成本。本研究在荷兰开展了一项横断面研究,旨在了解 PKU 患者或其照顾者的个人时间负担和生活成本。

方法

系统检索了与 PKU 管理相关的所有方面,以确定这些方面是否会给患者或照顾者带来经济或时间负担。通过与 PKU 专家访谈以及征求患者和照顾者的反馈,对研究结果进行了确认,并将这些发现整合到一个旨在评估这些因素对患者和照顾者影响的问卷中。该问卷由来自 7 家代谢中心的早期持续治疗的成年患者和照顾者在线填写。

结果

共有 22 名成年患者和 24 名照顾者参与了本研究。对于照顾者来说,管理低 Phe 饮食会额外增加 1 小时 24 分钟的时间负担,而成年患者则需要额外 30 分钟。照顾者的时间负担明显高于成年患者。患者的年总自付费用(OOPC)中位数为 604 欧元,其中 99%用于低蛋白食品。疾病严重程度较高与成年患者和照顾者的 OOPC 和时间负担增加显著相关。

结论

PKU 的管理对 PKU 患儿的照顾者和成年患者来说都是一个沉重的负担。与成年患者相比,PKU 患儿的照顾者报告的时间负担要重得多。照顾者和患者的 OOPC 主要由低蛋白食品的支出驱动。

相似文献

1
The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.苯丙酮尿症的耗时性:一项横断面研究,调查荷兰苯丙酮尿症的时间负担和成本。
Mol Genet Metab. 2013 Jul;109(3):237-42. doi: 10.1016/j.ymgme.2013.05.003. Epub 2013 May 10.
2
The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.苯丙酮尿症患儿照料者的个人负担:一项调查英国时间负担和成本的横断面研究。
Mol Genet Metab Rep. 2016 Aug 28;9:1-5. doi: 10.1016/j.ymgmr.2016.08.008. eCollection 2016 Dec.
3
Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study.中国苯丙酮尿症的家庭经济负担及其对治疗的影响:一项横断面研究
J Inherit Metab Dis. 2017 May;40(3):369-376. doi: 10.1007/s10545-016-9995-0. Epub 2016 Nov 10.
4
Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.苯丙酮尿症等遗传性代谢病的饮食模式、费用及低蛋白饮食依从性。
Eur J Clin Nutr. 2018 Jan;72(1):87-92. doi: 10.1038/ejcn.2017.102. Epub 2017 Jun 28.
5
Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.早期治疗苯丙酮尿症患者的心理健康和社会功能:PKU-COBESO 研究。
Mol Genet Metab. 2013;110 Suppl:S57-61. doi: 10.1016/j.ymgme.2013.10.011. Epub 2013 Oct 22.
6
Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.评价引入四氢生物蝶呤(BH4)前后苯丙酮尿症(PKU)患者的生活质量:一项前瞻性多中心队列研究。
Mol Genet Metab. 2013;110 Suppl:S49-56. doi: 10.1016/j.ymgme.2013.09.015. Epub 2013 Sep 25.
7
The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.沙丙蝶呤对苯丙酮尿症患者尿中单胺代谢物的影响。
Mol Genet Metab. 2013 Jul;109(3):243-50. doi: 10.1016/j.ymgme.2013.04.017. Epub 2013 May 1.
8
The challenges of managing coexistent disorders with phenylketonuria: 30 cases.苯丙酮尿症合并其他疾病的管理挑战:30例病例
Mol Genet Metab. 2015 Dec;116(4):242-51. doi: 10.1016/j.ymgme.2015.10.001. Epub 2015 Oct 9.
9
Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire.苯丙酮尿症生活质量问卷(PKU-QOL)美国英语版的编制。
Health Qual Life Outcomes. 2017 Mar 9;15(1):46. doi: 10.1186/s12955-017-0620-1.
10
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.成人苯丙酮尿症患者躯体共病的系统文献综述。
Orphanet J Rare Dis. 2024 Aug 12;19(1):293. doi: 10.1186/s13023-024-03203-z.

引用本文的文献

1
Global Clinical Practice in Transitioning Protein Substitutes for Children with Phenylketonuria.苯丙酮尿症患儿蛋白质替代物转换的全球临床实践
Nutrients. 2025 Aug 15;17(16):2650. doi: 10.3390/nu17162650.
2
Our lives with PKU: German patient voices - "Nothing about us without us".我们与苯丙酮尿症相伴的生活:德国患者的心声——“没有我们的参与,就没有关于我们的一切”
Mol Genet Metab Rep. 2025 Mar 4;43:101201. doi: 10.1016/j.ymgmr.2025.101201. eCollection 2025 Jun.
3
Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population.
利用认知和言语生态瞬时评估法研究苯丙酮尿症患者:罕见病群体认知波动的开发与可用性研究
JMIR Form Res. 2025 Jun 3;9:e63644. doi: 10.2196/63644.
4
Caregiver-Reported Economic Impacts of Pediatric Rare Diseases-A Scoping Review.照顾者报告的儿科罕见病的经济影响——一项范围综述
Healthcare (Basel). 2024 Dec 21;12(24):2578. doi: 10.3390/healthcare12242578.
5
Parental and child's psychosocial and financial burden living with an inherited metabolic disease identified by newborn screening.新生儿筛查确诊的遗传性代谢疾病患儿及其父母的心理社会和经济负担
J Inherit Metab Dis. 2025 Jan;48(1):e12784. doi: 10.1002/jimd.12784. Epub 2024 Aug 27.
6
Comparison of Cost Analysis in Patients with Tetrahydrobiopterin-Responsive and Non-Responsive Phenylketonuria in Turkey.土耳其四氢生物蝶呤反应性与非反应性苯丙酮尿症患者的成本分析比较。
Nutrients. 2024 May 10;16(10):1444. doi: 10.3390/nu16101444.
7
Methods used to account for caregivers' sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review.在研究儿童和青少年照料者的经济负担时,用于考量照料者性别和性别的方法:一项范围综述的结果
Clinicoecon Outcomes Res. 2024 Jan 26;16:35-53. doi: 10.2147/CEOR.S443077. eCollection 2024.
8
Natural Protein Intake in Children with Phenylketonuria: Prescription vs. Actual Intakes.苯丙酮尿症患儿的天然蛋白质摄入量:处方摄入量与实际摄入量。
Nutrients. 2023 Nov 23;15(23):4903. doi: 10.3390/nu15234903.
9
Becoming a Rare Disease Parent: An Interpretative Phenomenological Analysis of Parent-Caregivers' Postpartum Experiences.成为罕见病患儿的家长:对产后阶段家长照顾者经历的诠释现象学分析
Qual Health Res. 2024 Jan;34(1-2):126-140. doi: 10.1177/10497323231205419. Epub 2023 Oct 25.
10
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.用于治疗苯丙酮尿症的合成生物制剂的疗效和安全性:一项 2 期临床试验。
Nat Metab. 2023 Oct;5(10):1685-1690. doi: 10.1038/s42255-023-00897-6. Epub 2023 Sep 28.